Search Results
Search for other papers by Nicolai Preisler in
Google Scholar
PubMed
Search for other papers by Pascal Laforêt in
Google Scholar
PubMed
Search for other papers by Karen Lindhardt Madsen in
Google Scholar
PubMed
Search for other papers by Edith Husu in
Google Scholar
PubMed
Search for other papers by Christoffer Rasmus Vissing in
Google Scholar
PubMed
Search for other papers by Gitte Hedermann in
Google Scholar
PubMed
Search for other papers by Henrik Galbo in
Google Scholar
PubMed
Search for other papers by Christopher Lindberg in
Google Scholar
PubMed
Search for other papers by John Vissing in
Google Scholar
PubMed
Objective
Pompe disease (glycogenosis type II) is caused by lysosomal alpha-glucosidase deficiency, which leads to a block in intra-lysosomal glycogen breakdown. In spite of enzyme replacement therapy, Pompe disease continues to be a progressive metabolic myopathy. Considering the health benefits of exercise, it is important in Pompe disease to acquire more information about muscle substrate use during exercise.
Methods
Seven adults with Pompe disease were matched to a healthy control group (1:1). We determined (1) peak oxidative capacity (VO2peak) and (2) carbohydrate and fatty acid metabolism during submaximal exercise (33 W) for 1 h, using cycle-ergometer exercise, indirect calorimetry and stable isotopes.
Results
In the patients, VO2peak was less than half of average control values; mean difference −1659 mL/min (CI: −2450 to −867, P = 0.001). However, the respiratory exchange ratio increased to >1.0 and lactate levels rose 5-fold in the patients, indicating significant glycolytic flux. In line with this, during submaximal exercise, the rates of oxidation (ROX) of carbohydrates and palmitate were similar between patients and controls (mean difference 0.226 g/min (CI: 0.611 to −0.078, P = 0.318) and mean difference 0.016 µmol/kg/min (CI: 1.287 to −1.255, P = 0.710), respectively).
Conclusion
Reflecting muscle weakness and wasting, Pompe disease is associated with markedly reduced maximal exercise capacity. However, glycogenolysis is not impaired in exercise. Unlike in other metabolic myopathies, skeletal muscle substrate use during exercise is normal in Pompe disease rendering exercise less complicated for e.g. medical or recreational purposes.
